Distribuzione geografica
Continente #
NA - Nord America 18.435
EU - Europa 1.845
AS - Asia 1.657
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 11
OC - Oceania 11
SA - Sud America 2
Totale 21.973
Nazione #
US - Stati Uniti d'America 18.423
CN - Cina 972
FI - Finlandia 499
VN - Vietnam 481
SE - Svezia 397
DE - Germania 336
UA - Ucraina 179
GB - Regno Unito 170
SG - Singapore 163
IT - Italia 152
FR - Francia 31
IE - Irlanda 29
IN - India 27
NL - Olanda 21
CA - Canada 11
EU - Europa 10
AU - Australia 7
MA - Marocco 7
BG - Bulgaria 5
CZ - Repubblica Ceca 4
ET - Etiopia 4
NZ - Nuova Zelanda 4
TR - Turchia 4
BE - Belgio 3
CH - Svizzera 3
IR - Iran 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
JP - Giappone 2
NO - Norvegia 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
DK - Danimarca 1
HU - Ungheria 1
IQ - Iraq 1
KR - Corea 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
Totale 21.973
Città #
Fairfield 3.199
Woodbridge 1.941
Houston 1.595
Chandler 1.560
Ashburn 1.321
Wilmington 1.172
Seattle 1.144
Ann Arbor 1.137
Cambridge 1.085
Jacksonville 991
Princeton 541
Dong Ket 480
San Diego 323
Beijing 275
Roxbury 224
Medford 210
Nanjing 208
Des Moines 173
Helsinki 173
Boardman 154
Singapore 93
Hebei 65
Norwalk 62
Padova 61
Nanchang 60
Shenyang 60
Jiaxing 50
London 46
Changsha 43
Tianjin 42
Redwood City 32
Dublin 29
New York 27
Guangzhou 26
Jinan 26
Kilburn 18
Washington 16
Ogden 14
Indiana 12
Borås 11
Detroit 11
Hefei 9
Rockville 9
Tappahannock 9
Zhengzhou 9
Chicago 7
Chiswick 7
Falls Church 7
Hangzhou 7
Mestre 7
Los Angeles 6
Ningbo 6
Nürnberg 6
Shanghai 6
Southwark 6
Taizhou 6
Wandsworth 6
Amsterdam 5
Milan 5
Muenster 5
Prescot 5
Sofia 5
Addis Ababa 4
Dallas 4
Fuzhou 4
Kharkiv 4
Kunming 4
Lanzhou 4
Nutley 4
Phoenix 4
Rabat 4
San Francisco 4
Taiyuan 4
Treviso 4
Yuncheng 4
Acton 3
Chengdu 3
Civitanova Marche 3
Fremont 3
Haikou 3
Hounslow 3
Mainz 3
Olomouc 3
Orange 3
Plaidt 3
Pune 3
Rome 3
Salé 3
Venice 3
Wuhan 3
Yellow Springs 3
Yenibosna 3
Ardabil 2
Auckland 2
Augusta 2
Chongqing 2
Colombes 2
Florence 2
Hamilton 2
Las Vegas 2
Totale 18.967
Nome #
1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia. 178
Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma - Characterization of the dysfunctional protein C Padua(3) (Protein CR-1L/propeptide) 134
Activated protein C resistance in normal and pre-eclamptic pregnancies 133
Type IIB von Willebrand Factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets 120
Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis. 116
Venous thrombosis in von Willebrand disease as observed in one centre and as reported in the literature. 115
Platelet serotonin and platelet aggregation in the differential diagnosis of thrombocytosis 112
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. 110
Bernard-Soulier Syndrome: diagnosis by ELISA method using monoclonal antibodies in 2 new unrelated patients 109
Aspirin and bleeding time 109
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 109
Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. 106
Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura. 105
Heparin induced thrombocytopenia: Prevalence in a large cohort of patients and confirmed role of PF4/heparin complex as the main antigen for antibodies 104
Multiple, relapsing thrombosis in a young man with primary thrombocytosis 104
Selection of both normal and bleeding patients is indicated before desmopressin administration 103
Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes 103
The significance of thrombocytosis in old age 99
The biological inertia of coumarin-induced pre-factors (so called PIVKAs) 99
The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance 99
The significance of plasma and /or platelet activated products after apheresis procedures 99
Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP. 98
Conformation sensitive gel electrophoresis for detection of factor X gene mutations 97
Plasma and platelet beta-thromboglobulin levels in patients with May-Hegglin anomaly 97
Associated risk factors and arterial occlusions in patients with von Willebrand disease: Analysis of the literature and report of two cases 97
Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome. 97
Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study 97
Heterozygous protein-S deficiency: a study of a large kindred. 96
Clinical and laboratory factors that affect the post-transfusion platelet increment 95
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. 95
Remission in hairy cell leukemia-variant following splenic radiotherapy alone 94
Normal and low molecular weight heparins: interaction with human platelets 94
Thrombotic manifestations in plasminogen deficiency and in plasminogen abnormalities. 94
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma 94
Familial thrombocythemia and/or thrombocytosis: apparently a rare disorder 93
Pitfalls of protein C assays in patients with activated protein C resistance 93
Thrombosis-free surgical procedures in severe (Homozygote) factor XII deficiency: report of four additional cases and literature review 93
Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy. 93
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected 93
Plasma fibrinolytic capacity in renal transplant recipients: Effect of steroid-free immunosuppression therapy. 93
Naturally occurring Arg-1 to Leu mutation in human protein C (protein C Padua(3)) resulting in an abnormal propeptide processing and in a molecule with discrepant functional activities 93
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome 92
A novel type I factor X variant (factor X Cys350Phe) due to loss of a disulfide bond in the catalytic domain 92
Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura 92
Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. 91
A new ELISA method for the detection of serum bindable anti-platelet antibodies (SPBIG). 91
Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis. 90
Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: Report of four cases and review of the literature 89
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family 89
Childhood stroke associated with familial protein S deficiency. 89
Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves. 89
Complex History of the Discovery and Characterization of Congenital Factor X Deficiency. 88
A new global test for the evaluation of the protein C-protein S system. 87
Use of a radioimmunoassay for 5-hydroxytryptamine (5-HT) in thrombocytosis 87
Unexpected low prevalence of FVIII gene inversion in severe hemophilia A patients from north-eastern Italy 86
Mild bleeding diathesis in a boy with combined severe haemophilia B (C(10400)-->T) and heterozygous factor V Leiden 86
The relationship between defective heparin cofactor activities and thrombotic phenomena in AT III abnormalities. 86
EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. 85
Clinical significance of beta-thromboglobulin in patients with high platelet count 85
Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. 85
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. 85
Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. 85
Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders 85
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX) 84
Discrepancies between von Willebrand factor multimeric composition and other tests in some von Willebrand's disease variants. 83
Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia 83
Normal pregnancy and delivery in essential thrombocythemia even without interferon therapy 83
Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes). 83
Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. 83
The evaluation of factor VIII antigen by means of a simple slide test. 82
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 82
Inhibitory effect of prostacyclin and nitroprusside on type IIB von Willebrand factor-promoted platelet activation. 82
Thrombotic Events in Asymptomatic FXII Deficiency versus Symptomatic FXI Deficiency: Surprising Observations. 81
Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. 81
Detection of B-cell monoclonality in fine needle aspiration by PCR analysis 81
Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor. 80
Platelet aggregation induced by plasma from type IIB von Willebrand's disease patients is associated with an increase in cytosolic Ca2+ concentration. 80
Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis 80
Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. 80
Phenotype and genotype expression in pseudohomozygous factor VLEIDEN : the need for phenotype analysis. 79
The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature. 79
The effect of anticoagulant mixtures on BTG and PF4 levels. 79
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 79
Partial gene deletion in a family with factor X deficiency. 79
The risk of fetal loss in family members of probands with factor V Leiden 78
APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems 78
Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors 78
A frequent factor XII gene mutation in Hageman trait. 78
Thrombotic events in homozygotes with a proven or highly probable Arg304Gln Factor VII mutation (FVII Padua) 1): only limited replacement therapy is needed in case of surgery 78
Thrombotic events in severe FXII deficiency in comparison with unaffected family members during a long observation period 78
The management of feto-maternal alloimmune thrombocytopenia: Report of three cases 77
Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism - an overview 77
Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation 77
Incidence of thrombocytosis in lymphomas 77
Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: a critical evaluation of reported cases 77
Platelet-derived factor V/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C 76
Totale 9.202
Categoria #
all - tutte 74.045
article - articoli 74.045
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.090

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019775 0 0 0 0 0 0 0 0 0 0 0 775
2019/20205.267 878 178 68 302 549 393 459 595 702 543 327 273
2020/20213.183 197 245 125 279 108 194 73 309 443 217 373 620
2021/20224.267 69 486 433 366 130 301 209 513 200 75 506 979
2022/20233.103 691 289 107 332 548 405 4 190 346 16 133 42
2023/20241.073 67 191 167 105 90 91 72 54 41 13 162 20
Totale 22.114